Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Wall Street, stocks
Stock market today: Wall Street mostly rises after encouraging inflation data despite Lilly's drag
Most U.S. stocks rose following an encouraging update on inflation, but drops for Eli Lilly and some other influential stocks kept indexes in check. The S&P 500 edged up 0.1% Tuesday, and three out of four stocks in the index were higher.
Drops for Lilly and Big Tech weigh on Wall Street, even as most stocks rise
Drops for Eli Lilly and other influential companies are weighing on U.S. indexes Tuesday, even though most of the market is rising following an encouraging update on inflation.
Stock Market Today: Asian Shares Advance After Inflation Data Drives a Rally on Wall Street
Asian Shares Advance After Inflation Data Drives a Rally on Wall Street TOKYO (AP) — Asian shares mostly rose Thursday, following a rally on Wall Street driven by encouraging update on U.S. inflation.
24/7 Wall St
3d
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
However, as investors, we care about the stock price years down the line and what
Eli
Lilly
will do in the next 3 to 5 years and beyond. That is why 24/7
Wall
Street
looks at projected revenue ...
4d
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday
Turning to 2025 guidance, Lilly noted that new medicines and new uses of existing medicines, expansion of production, and ...
3d
on MSN
Eli Lilly cuts Q4 sales forecast, but analyst remains bullish on stock—here’s why
Eli Lilly trims Q4 guidance but maintains optimism with promising drugs like Zepbound for sleep apnea and global launches ...
STAT
3d
Eli Lilly CEO on Trump, obesity drugs, and a guidance miss
In a live taping of "The Readout LOUD" at #JPM25, Eli Lilly CEO Dave Ricks talks Trump, Medicare's drug price negotiation, ...
4d
Eli Lilly & Co: Strong Growth Prospects and Strategic Positioning Justify Buy Rating
Eli Lilly & Co (LLY – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Evan ...
Finbold | Finance in Bold
4d
Here’s why Eli Lilly stock is crashing
Eli Lilly (NYSE: LLY) saw its stock decline sharply by 6.5% on January 14, following the release of its fourth-quarter 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback